Naltrexone for Impulse Control Disorders in Parkinson's Disease

Clinical trial NCT01052831 · COMPLETED

Trial details

NCT number: NCT01052831
Sponsor: University of Pennsylvania
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Impulse Control Disorder Parkinson Disease

Start date: 2009-11-01
Primary completion: 2012-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.